Company
Keenova Therapeutics plc (0001567892)
Standardized SEC financial data for Keenova Therapeutics plc — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001567892 · Pharmaceutical Preparations.
Gross margin
44.9%
Operating margin
-24.3%
Net margin
-34.2%
Revenue growth (YoY)
32.0%
Return on equity
-23.7%
ROIC
-7.2%
Free cash flow
$74.6M
Debt / equity
1.23×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2019 | FY2020 | FY2021 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $3.16B | $2.21B | $2.21B | $949.2M | $1.08B | $1.43B |
| Cost of revenue |
Balance sheet
| USD | FY2022 | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $447.3M | $466.7M | $235.4M | $300.1M | $368.3M | $954.0M |
| Inventory |
Cash flow
| USD | FY2019 | FY2020 | FY2021 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $742.9M | $498.9M | $455.4M | -$412.1M | $160.7M | $125.0M |
| Capital expenditures |
Get 0001567892 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001567892/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001567892/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"